
Pharma Sees Viagra Sales to Fall Down as Exclusivity Expired
By Rahul Gotadki , 14 April, 2023
Viagra has been approved by the U.S. Food and Drug Administration (FDA) to treat male erectile dysfunction. Initially, it was used for hypertension, high blood pressure, and chest pain associated with coronary heart disease.
According to the reports, sildenafil is the generic drug name, later marketed as Viagra. It has been found to induce penile erections sometimes during clinical trials; after that, Pfizer decided to study and sell the drug for erectile dysfunction too. As per the reports, Pfizer's drug became an instant success reaching above $1 billion in global sales in its second year.
North America is the largest region in the erectile dysfunction (ED) drugs market in 2022.Middle East is expected to be the fastest growing region in the forecast period.
In 2013, Pfizer's patent on the usage of sildenafil for erectile dysfunction expired in the European Union. Thus, its success story began to fade even after being a most recognizable drug and often synonymous with sexual performance enhancement. The reports further revealed, at that time, the company in the United States was involved in a patent lawsuit which resulted in the settlement of Teva Pharmaceuticals to launch a generic version of Viagra in 2017.
The loss of exclusivity was seen in major markets such as Japan, Europe, and mainly in the United States, and Viagra sales had a significant effect. Reports have proven that it declined by almost 70 percent between 2012 and 2018. The company's off-patent branded and generic business Upjohn in 2020, which also included Viagra, was spun off later and combined with Mylan to create a new company called Viatris.Viagra's $32.6 Billion Run

Latest News

In 2025, the bio-based resin sector is experiencing significant growth, driven by stringent environmental regulations and a resurgence of investor confidence. The global market is set to experience rapid market growth between 2025 and 2030, driven by…

In 2025, the momentum for hydrogen projects on a global level is radically increasing, incorporating hydrogen as a key component alongside other global energy transitions. The introduction of agile capital, regulation, and infrastructure during 2025…

In 2025, The “Cobots” Adoption in SMEs Market will Begin Transitioning as Small and Medium Sized Enterprises (SMEs) in Europe, Asia, and North America are cross-adopting collaborative robots (cobots) to enhance intralogistics and material handling…

The unprecedented funding of Industrial Internet of Things (IIoT) startups in Q2 marks a new record, indicating strong investors' confidence against the backdrop of an ongoing digital transformation. IIoT startups seem to be enjoying the animated…

By 2025, Tesla and BMW have adopted predictive maintenance as a way to optimize operations within the automotive industry. Both companies have established AI maintenance systems to address equipment failures which has greatly improved unplanned…

Assistant Manager
Latest News




